Early research (Phase 1)Ended earlyNCT05027815
What this trial is testing
Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)
Who this might be right for
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Jeffrey Bluestone 7